Shape Vantage Review
Tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10
Best for: no one; listed so a search for the name reaches this caution
Shape Vantage falls below our bar on disclosure. Its compounded tirzepatide costs $199.67 a month, paid up front, 26% below the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Shape Vantage sells one product, a 3-month tirzepatide kit, through a direct Stripe link with no medical intake. Its terms make provider review something that happens only where required. The homepage advertises $399; the checkout it links to charges $599. GLP Watchdog does not recommend Shape Vantage.
Is Shape Vantage legit?
Shape Vantage does not name the company behind it anywhere on its site or in its legal pages, so we could not confirm who you would be buying from. We found no FDA warning letters issued under the Shape Vantage name. We rate it 7.0/10 overall, across six areas from price to trust and safety. Find out who operates it before you pay, and raise any doubts with a licensed clinician.
See how Shape Vantage compares on our rankings of the best tirzepatide providers.
Vetted alternatives to Shape Vantage
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Found
Best for: people who want clinician visits billed to commercial insurance, with compounded medication in the plan price
Editorial score · methodology
Shape Vantage at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Tirzepatide
- Starting price
- $199.67/mo
- FDA status
- No FDA warning letters found
How Shape Vantage scores
Six columns, each one computed from something Shape Vantage has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
6.0/10$199.67/month is 26% below the $269 median for compounded tirzepatide across the sellers we compare. Every listed price requires paying for several months up front, so Value is capped at 6.
Effectiveness25%
10.0/10Dispenses tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
5.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Shape Vantage
Last checked October 2026- Checked the listed price across 1 dose or plan tier
- Checked FDA warning letters for Shape Vantage
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Shape Vantage involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Shape Vantage shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Shape Vantage which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Lowest ongoing monthly price: tirzepatide $199.67. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Shape Vantage serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Medications Shape Vantage lists
Shape Vantage lists compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
The Stripe checkout reads $599.00 for the 3-month program. The homepage button says $399.
Check the price yourself before you pay
Every figure here comes from Shape Vantage's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $199.67 a month, 26% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- We found no FDA warning letters issued to Shape Vantage
Against it
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its tirzepatide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our verdict: listed as a caution, not a recommendation
GLP Watchdog does not recommend Shape Vantage. The register carries the listing anyway, so that a search for the name reaches an honest assessment rather than the marketing site. Tirzepatide is genuinely for sale here, and our tirzepatide page explains what the drug is. Missing is everything that makes a licensed compounded-telehealth service, of the kind filling the rest of this directory, recognizable as medical care. One product. One direct checkout link. No clear requirement that a doctor sees your order before it ships. Our confidence in this provider is LOW, and that last item is the reason.
One published price, and no dose ladder behind it
Shape Vantage prices one product two ways. The homepage advertises one figure; the Stripe checkout it links to charges a higher one, about $199.67 a month across the three months. Neither sits behind an intake form. Read what it buys and the simplicity stops being a virtue. The company describes the charge as a one-time "Full 3-Month Program": a tirzepatide formulation kit sold once, as a bundle, not a subscription whose dosing follows your progress. Nothing is published about titration. No dose ladder appears, and neither does a per-month rate. Providers we track typically charge around $167 monthly, with the medical structure this listing lacks.
Payment comes before medicine here. From the homepage, a Stripe checkout link is the next step, and nothing sits between you and it: no questionnaire about your health, no consultation, no prescription check. On a legitimate prescription platform, a drug like tirzepatide cannot reach a payment screen until a clinician has read your intake. A seller that does not require a screening and a prescription by a licensed doctor is one of the FDA's own warning signs for telehealth sellers. That sequence is inverted, which leaves medical review optional at best.
The review that only happens where required
Two hedges in the Terms of Service decide this review, and we found them by reading the document line by line. Under the medical disclaimer, the qualifier is "if applicable": licensed providers or "compliant partners" handle clinical services and prescriptions where that condition holds. Under eligibility, the qualifier is "where required": whether the program is open to you may turn on provider review. Neither qualifier belongs on a prescription pathway. At a genuine compounded-telehealth service, every order goes to a provider, without exception. What Shape Vantage has written down instead is a right to ship whenever it judges the law to be silent. Given that the drug is an injectable, we treat that as disqualifying rather than as a technicality.
What is absent that should be present
Every GLP-1 provider gets audited against the same markers of an accountable medical operation. Shape Vantage carries almost none:
- No accreditation visible. LegitScript certification is absent. So is any NABP or state pharmacy-board listing, and so is PCAB compounding accreditation.
- No named pharmacy. The site never says which licensed compounding pharmacy, or which "compliant partner," actually fills the order. Without a name you cannot check whether it is a 503A pharmacy or a 503B outsourcing facility, or whether it is licensed at all.
- No clinical language at all. Search the homepage for doctor, physician, prescription, consultation, or telehealth visit and nothing comes back.
- A prescription drug carrying a supplement's disclaimer. On the page sits the standard dietary-supplement formula, a claim that the product does not diagnose, treat, cure, or prevent disease. That sentence belongs to supplements and research-use-only peptide vendors, whose labels FDA rejects in its warning letters. FDA-approved and legitimately compounded prescription medicines are not labeled that way.
- No corporate transparency. The legal entity goes unnamed and the state of incorporation is undisclosed. All the site commits to is that California law governs.
- No state-availability map and no brand-name path. Nothing tells you which states it can lawfully serve, and FDA-approved brand options go unmentioned.
What the tech stack gives away
Treat this as a minor signal that fits everything above. Shape Vantage is built with WordPress and the Elementor page builder, consumer-grade tooling aimed at blogs and small storefronts. Compounded-GLP-1 platforms with any track record run custom commerce and patient-management software instead, because somebody has to turn an intake into a prescription and a prescription into a shipment from a pharmacy. A page builder wired to a payment link does none of that work.
Who it suits, and who should stay away
No group of patients has a good reason to choose Shape Vantage, and we could not construct one. Skip Shape Vantage if you value your safety. If you want tirzepatide, use a provider whose clinician reads your health history, prescribes on that basis, and stands behind a named, accredited pharmacy. Even from such a provider, FDA has never reviewed compounded tirzepatide for safety, effectiveness or quality. Here the prescriber is not guaranteed, nothing is accredited, and the origin of the drug is never stated. Buying an injectable that way is a shortcut that can go badly, with nobody in place to catch it when it does.
Why we rate our confidence LOW
Begin with what held up. The tirzepatide offering is real. A price is published, though not the one checkout charges. A Terms of Service exists, and it does disclose that California law governs the relationship. Our last check turned up no FDA warning letter against the company either. That last finding proves less than it looks like: no letter yet is not a safety record. Set it against the rest and the balance is clear. The prescription pathway is optional, no accreditation is visible, no pharmacy is named, the disclaimers are supplement-grade, and checkout comes first. Together those put Shape Vantage in a riskier class than the LegitScript-certified platforms ranked elsewhere here. How each factor is weighed is set out on our scoring methodology page.
Bottom line
The product page is polished. Behind it is a tirzepatide reseller whose medical review is conditional rather than mandatory, holding none of the accreditation a prescription drug warrants. Its price is on the page, but checkout charges more than the homepage says, and a published price says nothing about who writes the prescription, who fills it, or whether a clinician is involved in any of it. We do not recommend Shape Vantage. Confirm how a prescription is actually issued before a card number goes in, and think hard about an accredited provider instead.
Belle Health ($199/month) and Collective ($59/month + membership) sit closest to Shape Vantage in what they charge and what they dispense.
The Bottom Line
Shape Vantage falls below our bar on disclosure. Its compounded tirzepatide costs $199.67 a month, paid up front, 26% below the $269 median among the sellers we compare.
Before you pay Shape Vantage
Starting at $199.67 a month. Check today's price, then start the intake.
Where Shape Vantage is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Found.
If none of these fits, our guide to alternatives to Shape Vantage sets more sellers in the same category beside Shape Vantage on price, states and what the price includes.
Frequently Asked Questions
How to check Shape Vantage yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Shape Vantage review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 7.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See Shape Vantage's current pricing
Plans start at $199.67 a month. Whether you qualify is a clinician's decision, made after your intake.